Study of BM230 in Patients With Advanced Solid Tumors
Clinical trial NCT06644300 · RECRUITING
Trial details
- NCT number
- NCT06644300
- Sponsor
- Suzhou Biomissile Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2027-12-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.